Breaking Medical News and In Depth Medical Stories

Search News:
Generic drug Finasteride reduces risk of prostate cancer
Generic drug Finasteride reduces risk of prostate cancer (August 14, 2013 - Insidermedicine) From Texas - The drug Finasteride may reduce risk of prostate cancer, according to a report released by the Cancer Therapy & Research Center at the University of Texas. Researchers studied 19,000 men, randomizing participants to placebo or to finasteride--a generic drug used to treat enlarged prostate and male pattern baldness. Participants had a median age of 62 and took the drug for 7 years. Results showed that the drug reduced risk of prostate cancer by 30% and risk of low grade tumours by 43%. Though there originally appeared to be an increased risk of high grade prostate tumours, this difference shrank in the follow-up period. As well, the 18 year follow-up found that the drug did not impact overall survival or risk of dying from prostate cancer.